Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding | 2.17% | $22.12M | $541.45B | 89.04% | 81 Outperform | |
| Roche Holding AG | 1.20% | $12.17M | CHF280.54B | 43.37% | 73 Outperform | |
| Novartis | 1.19% | $12.11M | $298.98B | 48.60% | 80 Outperform | |
| Royal Bank Of Canada | 0.98% | $10.02M | $245.41B | 47.13% | 75 Outperform | |
| AstraZeneca | 0.88% | $8.93M | £219.61B | 20.01% | 80 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 0.72% | $7.35M | €267.29B | -23.77% | 78 Outperform | |
| Toyota Motor | 0.70% | $7.08M | ¥48.41T | 32.64% | 80 Outperform | |
| Rolls-Royce Holdings | 0.66% | $6.73M | £104.84B | 125.89% | 71 Outperform | |
| ― | 0.64% | $6.50M | ― | ― | ― | |
| Unilever | 0.63% | $6.37M | $155.99B | 13.35% | 73 Outperform |